PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
3.490
+0.070 (2.05%)
At close: Aug 13, 2025, 4:00 PM
3.490
0.00 (0.00%)
After-hours: Aug 13, 2025, 5:15 PM EDT
PolyPid Market Cap
PolyPid has a market cap or net worth of $35.57 million as of August 13, 2025. Its market cap has increased by 116.15% in one year.
Market Cap
35.57M
Enterprise Value
15.09M
1-Year Change
116.15%
Ranking
Category
Stock Price
$3.49
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has decreased from $82.43M to $35.57M, a decrease of -56.85%. That is a compound annual growth rate of -15.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 34.85M | 68.51% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | 183.09M | 122.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 589.50B |
| Johnson & Johnson | 418.86B |
| AbbVie | 355.22B |
| UnitedHealth Group | 244.53B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 225.13B |
| Novo Nordisk | 223.00B |